持股变动声明
PharmaCyte Biotech(PMCB)07-18 05:05
$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004918 Size: 5 KB 网页链接
简介:PharmaCyte Biotech, Inc.是一家成立于1996年的内华达州公司。该公司是一家生物技术公司,专注于开发和准备商业化基于专有的基于纤维素的活细胞封装技术的癌症、糖尿病和恶性腹水的细胞疗法,简称Cell-in-a-Box。该公司正致力于推进基于细胞的肿瘤和糖尿病新疗法的临床研究和开发。该小组一直在努力完成FDA要求的项目清单。该公司还在开发一种方法来延缓由多种类型的腹部癌性肿瘤引起的恶性腹水的产生和积累。该公司针对恶性腹水的治疗包括使用胰腺癌使用的相同的包膜细胞,但将包膜细胞置于患者的腹腔内,并静脉注射异环磷酰胺。除了这些癌症项目,该公司还在考虑如何利用Cell-in-a-Box技术的好处来开发癌症疗法,其中包括基于大麻植物某些成分的前体药物。
今开:2.03 | 昨收:2 |
最高:2.03 | 最低:1.95 |
涨停价: | 跌停价: |
总市值:16568656 |
PharmaCyte Biotech(PMCB)07-18 05:05
$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004918 Size: 5 KB 网页链接
PharmaCyte Biotech(PMCB)07-18 05:05
$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004916 Size: 5 KB 网页链接
PharmaCyte Biotech(PMCB)07-30 04:15
$PharmaCyte Biotech(PMCB)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001683168-24-005109 Act: 34 Size: 20 KB 网页链接
PharmaCyte Biotech(PMCB)05-24 04:45
$PharmaCyte Biotech(PMCB)$ 8-K Current report, items 1.01, 2.01, 8.01, and 9.01 Accession Number: 0001683168-24-003796 Act: 34 Size: 1 MB 网页链接
PharmaCyte Biotech(PMCB)07-18 05:05
$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004915 Size: 5 KB 网页链接
PharmaCyte Biotech(PMCB)07-18 05:05
$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004917 Size: 5 KB 网页链接
PharmaCyte Biotech(PMCB)05-31 04:15
$PharmaCyte Biotech(PMCB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001683168-24-003882 Act: 34 Size: 7 KB 网页链接
PharmaCyte Biotech(PMCB)05-31 04:15
$PharmaCyte Biotech(PMCB)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001683168-24-003883 Size: 52 KB 网页链接
药时代2022-10-12 16:27
2022年10月16日,为期4天的美国外科医师学会(ACS)临床大会将在美国西海岸的圣地亚哥隆重举办,自2019年疫情爆发以来,该会议已经连续两年于线上召开,今年将是重返线下的第一年。作为世界上最大的外科医生国际会议之一,全球很多顶尖外科医生都将汇聚于此。
不过对于大会的主办方来说,现在...查看全文
披风下的剑2021-08-19 20:04
Ai1682021-08-19 08:32
$DatChat(DATS)$ 基于区块链的网络安全社交媒体平台,前途无量!五星APP.即将暴涨的次新股。$PharmaCyte Biotech(PMCB)$ $Virpax(VRPX)$查看全文
在洛杉矶炒股的奶爸2021-08-19 02:11
$PharmaCyte Biotech(PMCB)$ vwap配合5分图果然是炒短线的指标王查看全文
阿pai2021-08-19 00:25
鲜克有终72021-08-18 21:44
鲜克有终72021-08-18 19:53
$PharmaCyte Biotech(PMCB)$ [好逊]奖励自己一根冰激凌查看全文
鲜克有终72021-08-18 19:50
$PharmaCyte Biotech(PMCB)$ 4.95buy 查看全文
不辍斋主2021-08-12 14:39
$PharmaCyte Biotech(PMCB)$ 这公司不是应该50倍起?查看全文
智通财经APP获悉,8月19日(周四)美股开盘,三大指数齐跌,道琼斯指数跌0.72%,报34709.86点;纳斯达克综合指数跌0.89%,报14525.91点;标普500指数跌0.73%,报4368.02点。 个股消息 生物技术公司PharmaCyte Biotech(PMCB.US)跌57.32%,该... 网页链接
$PharmaCyte Biotech(PMCB)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001683168-24-005109 Act: 34 Size: 20 KB 网页链接
$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004918 Size: 5 KB 网页链接
$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004917 Size: 5 KB 网页链接
$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004915 Size: 5 KB 网页链接
$PharmaCyte Biotech(PMCB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-004916 Size: 5 KB 网页链接
$PharmaCyte Biotech(PMCB)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001683168-24-003883 Size: 52 KB 网页链接
$PharmaCyte Biotech(PMCB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001683168-24-003882 Act: 34 Size: 7 KB 网页链接
$PharmaCyte Biotech(PMCB)$ 8-K Current report, items 1.01, 2.01, 8.01, and 9.01 Accession Number: 0001683168-24-003796 Act: 34 Size: 1 MB 网页链接
$PharmaCyte Biotech(PMCB)$ 8-K Current report, item 5.07 Accession Number: 0001683168-24-002881 Act: 34 Size: 206 KB 网页链接
$PharmaCyte Biotech(PMCB)$ ARS Annual Report to Security Holders Accession Number: 0001683168-24-001761 Act: 34 Size: 2 MB 网页链接